We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
-4.05%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.11B
AUM Growth
-$170M
Cap. Flow
-$54.7M
Cap. Flow %
-2.59%
Top 10 Hldgs %
25.5%
Holding
2,409
New
42
Increased
215
Reduced
756
Closed
94

Top Buys

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.75M
2
TSLA icon
Tesla
TSLA
+$1.84M
3
CSGP icon
CoStar Group
CSGP
+$1.61M
4
PCG icon
PG&E
PCG
+$1.12M
5
EQT icon
EQT Corp
EQT
+$955K

Sector Composition

Rank Sector Weight
1 Technology 21.19%
2 Healthcare 13.97%
3 Financials 12.12%
4 Consumer Discretionary 10.21%
5 Industrials 7.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBCAA icon
1876
Republic Bancorp
RBCAA
$1.92B
$26K ﹤0.01%
679
ITOS
1877
DELISTED
iTeos Therapeutics
ITOS
$26K ﹤0.01%
1,365
RMR icon
1878
The RMR Group
RMR
$346M
$26K ﹤0.01%
1,097
LOGC
1879
DELISTED
ContextLogic
LOGC
$25.9K ﹤0.01%
1,178
FLIC
1880
DELISTED
First of Long Island Corp
FLIC
$25.9K ﹤0.01%
1,504
BBBY
1881
DELISTED
Bed Bath & Beyond Inc
BBBY
$25.9K ﹤0.01%
4,252
OFIX icon
1882
Orthofix Medical
OFIX
$415M
$25.9K ﹤0.01%
1,354
CRMT icon
1883
America's Car Mart
CRMT
$25.7M
$25.9K ﹤0.01%
424
BHR
1884
Braemar Hotels & Resorts
BHR
$139M
$25.9K ﹤0.01%
6,016
+2,166
+56% +$11K
ULCC icon
1885
Frontier Group Holdings
ULCC
$1.57B
$25.9K ﹤0.01%
2,666
HRTX icon
1886
Heron Therapeutics
HRTX
$63.5M
$25.9K ﹤0.01%
6,126
INO icon
1887
Inovio Pharmaceuticals
INO
$93M
$25.8K ﹤0.01%
1,246
+585
+89% +$15K
FORG
1888
DELISTED
ForgeRock, Inc.
FORG
$25.8K ﹤0.01%
1,774
BMRC icon
1889
Bank of Marin Bancorp
BMRC
$462M
$25.6K ﹤0.01%
855
CCB icon
1890
Coastal Financial
CCB
$774M
$25.5K ﹤0.01%
641
CMPR icon
1891
Cimpress
CMPR
$2.37B
$25.5K ﹤0.01%
1,040
AGTI
1892
DELISTED
Agiliti Inc
AGTI
$25.4K ﹤0.01%
1,777
HYLN icon
1893
Hyliion Holdings
HYLN
$734M
$25.4K ﹤0.01%
8,860
+3,524
+66% +$12.8K
EWCZ
1894
DELISTED
European Wax Center
EWCZ
$25.4K ﹤0.01%
1,378
DCO icon
1895
Ducommun
DCO
$3.01B
$25.4K ﹤0.01%
641
ANIK icon
1896
Anika Therapeutics
ANIK
$283M
$25.4K ﹤0.01%
1,066
WRLD icon
1897
World Acceptance Corp
WRLD
$875M
$25.4K ﹤0.01%
262
DENN
1898
DELISTED
Denny's
DENN
$25.3K ﹤0.01%
2,691
-1,145
-30% -$11K
NKTR icon
1899
Nektar Therapeutics
NKTR
$2.57B
$25.2K ﹤0.01%
526
-209
-28% -$12.4K
KPTI icon
1900
Karyopharm Therapeutics
KPTI
$45.1M
$25.2K ﹤0.01%
308
+131
+74% +$9.79K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2022 Portfolio in Review

As of Q3 2022, Metropolitan Life Insurance Company (MetLife) held 2,409 positions worth $2.11B, down 7.5% from $2.28B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2022 filing shows 42 new, 215 increased, 756 reduced and 94 closed positions. Its largest new stake was CoStar Group: 23,153 shares worth $1.61M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $11.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2022 buy was CoStar Group: 23,153 shares worth $1.61M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares MSCI EAFE ETF in Q3 2022, an estimated $3.75M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $11.4M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Healthcare Realty Trust Incorporated in Q3 2022, selling an estimated $433K.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $2.11B portfolio in Q3 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 42 new positions and closed 94 in Q3 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 7.5% quarter-over-quarter to $2.11B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.